Table 4 Vasopressors usage
|  | Whole population (n = 53) | Noradrenaline ( n = 37) | No noradrenaline (n = 16) | p value |
|---|---|---|---|---|
TWA65 (mmHg) | 0.26 [0.04–0.65] | 0.22 [0.04–0.72] | 0.31 [0.07–0.54] | 0.469 |
TWA50 (mmHg) | 0 [0–0.01] | 0 [0–0.04] | 0 [0–0] | 0.107 |
Hypotension time (% surgery time) | 5 [1–10] | 4 [1, 2, 3, 4, 5, 6, 7, 8, 9] | 7 [0–11] | 0.605 |
Average MAP (mmHg) | 80 [71–90] | 80 [71–90] | 81 [71–93] | 0.979 |
Average HR (bpm) | 64 [58–73] | 62 [56–72] | 66 [70–74] | 0.680 |
Dobutamine (n,%) | 7 (13.2) | 6 (16.2) | 1 (7.7) | 0.660 |
Hypotensive episodes per patient | 4 [1, 2, 3, 4, 5, 6] | 3 [1, 2, 3, 4, 5, 6, 7] | 4 [1, 2, 3, 4, 5, 6, 7, 8, 9] | 0.459 |
Fluid balance (ml)a | 0.26 [0.04–0.58] |  − 0.720 [− 1297–590] |  − 0.386 [− 1045–1069] | 0.660 |